Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.35
Delayed Data
As of May 05
 -0.15 / -4.29%
Today’s Change
2.65
Today|||52-Week Range
6.35
-16.46%
Year-to-Date

Today’s Trading

Previous close3.50
Today’s open3.49
Day’s range3.33 - 3.49
Volume190,264
Average volume (3 months)221,496
Market cap$147.5M
Dividend yield--
Data as of 05/05/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-10.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
MSLIMerus Labs Internati...-0.01-0.69%
CYNACynapsus Therapeutic...-0.62-5.09%
TKAITokai Pharmaceutical...-0.18-2.68%
VVUSVIVUS Inc0.000.00%
Data as of 05/05/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts

Partner Offers

Search for Jobs